Methodist Health System: Clinical Trials

174 trials sponsored by Methodist Health System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

87 completed, 34 unknown, 20 recruiting, 12 withdrawn. 15 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 7, Unknown 4, Recruiting 2, Terminated 2
Phase 32Completed 1, Withdrawn 1
Phase 42Completed 2
Phase 11Withdrawn 1

Follow this sponsor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Psychosocial Burden and Quality of Life in Caretakers of Hepatobiliary Cancer Patients
Psychosocial Problem
RecruitingMethodist Health System1502026-05-262026-06-12
Endoscopic Retrograde Cholangiopancreatography
Patients undergoing ERCPs at Methodist Dallas Medical Center - Gastro-Intestinal Disorder
RecruitingMethodist Health System1002026-02-012026-03-24
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Semaglutide - Polycystic Ovary Syndrome
Phase 1WithdrawnMethodist Health System2026-02-012026-03-23
Monitoring the Response of Combination Ursodiol and Seladelpar Treatment
Blood Draws - Primary Biliary Cholangitis
Not yet recruitingMethodist Health System1002025-08-012025-08-14
Trauma Activation Criteria
over- and under-triage rates - Trauma
RecruitingMethodist Health System50002024-11-242026-03-24
Validation of COMPAT-SF Spanish Translation
Questionnaires - Chronic Pancreatitis
UnknownMethodist Health System1002024-09-132024-11-20
Evidence-based Approach to Reduce Falls in Adult Patients
Observation - Falls with Injuries
UnknownMethodist Health System10002024-07-232024-11-20
Blunt Traumatic Aortic Injury
Blunt Traumatic Aortic Injury, BTAI
Active not recruitingMethodist Health System3002024-04-082026-06-25
Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors
Peptide Receptor Radionuclide Therapy - Neuroendocrine Tumors, Gastroenteropancreatic Neuroendocrine Tumor
RecruitingMethodist Health System502024-03-282026-03-20
Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver Disease
NAFLD
Enrolling by invitationMethodist Health System2002024-02-232026-06-10
Enteric Anastomoses
Medical/Phenotype Data Collection Procedures & Data to be Collected - Trauma
RecruitingMethodist Health System1002024-02-162026-06-10
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
No Intervention - Bacteremia
CompletedMethodist Health System1462024-01-312026-08-04
Acute Subdural Hematoma
Medical/Phenotype Data Collection Procedures & Data to be Collected - Trauma
RecruitingMethodist Health System1002024-01-302026-08-04
Traumatic Cardiac Arrest
Medical/Phenotype Data Collection Procedures & Data to be Collected - Trauma
RecruitingMethodist Health System1002024-01-302026-08-04
Cardiac Clearance vs G60 Hip Frailty Index
Medical/Phenotype Data Collection Procedures & Data to be Collected - Cardiac Disease
RecruitingMethodist Health System1002024-01-302026-08-04
Emergency Medicine Pharmacist Prescriptive Authority for Resolution of Outpatient Prescription Issues
outpatient prescription issues - Outpatient Prescription Issues
Not applicableCompletedMethodist Health System3502023-12-152026-03-23
Leadership Training Affect Physician Career Satisfaction
evaluate the impact of organizational interventions for physician development on wellbeing - Leadership, Personality
Not applicableRecruitingMethodist Health System2002023-12-012026-03-20
Management of Extremity Injuries Registry
Non-Interventional (Registry) - Trauma
CompletedMethodist Health System9992023-10-312026-03-25
Penetrating Trauma Registry and Open Source Data
Treatment measures and intervention strategies - Penetrating Trauma Registry and Open Source Data
UnknownMethodist Health System2002023-08-152023-11-18
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
PK Papyrus Covered Coronary Stent System - Coronary Disease
Not applicableRecruitingMethodist Health System412023-08-102026-06-10

Showing 20 of 174. Sign in to see all of them.

Conditions studied

Wounds and Injuries (10)  ·  COVID-19 (8)  ·  Fibrosis (4)  ·  Liver Diseases (4)  ·  Obesity (4)  ·  Carcinoma, Hepatocellular (3)  ·  Digestive System Diseases (3)  ·  Gastrointestinal Diseases (3)  ·  Intracranial Aneurysm (3)  ·  Non-alcoholic Fatty Liver Disease (3)  ·  Pancreatic Neoplasms (3)  ·  Bile Duct Diseases (2)  ·  Cholangiocarcinoma (2)  ·  Diabetes Mellitus (2)  ·  Fatty Liver (2)

Interventions

Watchful Waiting (3)  ·  Anti-Bacterial Agents (2)  ·  Liver Transplantation (2)  ·  Surveys and Questionnaires (2)  ·  2019-nCoV Vaccine mRNA-1273 (1)  ·  Aminoglycosides (1)  ·  Ampicillin (1)  ·  Antimetabolites (1)  ·  Bariatric Surgery (1)  ·  Bisacodyl (1)  ·  Blood Specimen Collection (1)  ·  Cefazolin (1)  ·  Cholangiopancreatography, Endoscopic Retrograde (1)  ·  Colonoscopy (1)  ·  Contraindications (1)

Countries

United States (165)  ·  Canada (1)

Top investigators

Prashant Kedia, MD (10)  ·  Parvez Mantry, MD (7)  ·  Matthew Crotty, PharmD (6)  ·  Alejandro Mejia, MD (5)  ·  Conner McDaniel, MD (5)  ·  Michael Truitt, M.D. (5)  ·  Michael Truitt, MD (5)  ·  Andrew Karpisek, MD (4)  ·  Jennifer Burris, MD (4)  ·  Richard Meyrat, MD (4)  ·  Tamara Reiter, PharmD (4)  ·  Crystal Brown, PharmD (3)  ·  Dhiresh Jeyarajah, M.D. (3)  ·  Jessica Crotty, PharmD (3)  ·  Mangesh Pagadala, MD (3)

Results publications

PMID 14739871, PMID 17476864, PMID 19827166, PMID 24598596, PMID 26281644, PMID 27207181, PMID 29444707, PMID 32029370, PMID 32360804, PMID 32730756, PMID 33798541, PMID 34453519, PMID 36536958, PMID 37379584, PMID 37450086, PMID 38605438, PMID 41524130, PMID 42836951

NIH funding

U01AI134591 (1)